Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio
In This Article:
Sanofi (SNY) agreed to acquire biopharmaceutical company Blueprint Medicines (BPMC) in a deal worth
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.